Angiotensin II, a potent RAS-derived vasoconstrictor peptide involved in tumor angiogenesis, is a prognostic predictor of endometrial endometroid adenocarcinoma along with AT1R, VEGF, and human A-LAP, a potential AngII degradation marker (4). Here, AGT is linked to neoplasm.